• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. COCR TRANSCEND FEMORAL HEAD 32MM SLT TAPER MEDIUM; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. COCR TRANSCEND FEMORAL HEAD 32MM SLT TAPER MEDIUM; HIP COMPONENT Back to Search Results
Model Number 26000022
Health Effect - Clinical Code Metal Related Pathology (4530)
Type of Reportable Event Serious Injury
Event or Problem Description
Allegedly, the patient had metal on metal complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COCR TRANSCEND FEMORAL HEAD 32MM SLT TAPER MEDIUM
Common Device Name
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key11300680
Report Number3010536692-2021-00060
Device Sequence Number11605113
Product Code JDL
UDI-Device IdentifierM684260000221
UDI-PublicM684260000221
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K004043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2005
Device Explanted Year2018
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 02/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number26000022
Device Catalogue Number26000022
Device Lot Number114112742
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date01/27/2021
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/27/2021
Initial Report FDA Received Date02/09/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-